Advertisement
Advertisement
AKTS
Aktis Oncology, Inc. Common stock
23.30
USDSponsored
-0.64
-2.67%
Sep 11, 15:59 UTC -4
Closed
After-Market
23.40
+0.10
+0.44%
AKTS Earnings Reports
Positive Surprise Ratio
AKTS beat 1 of 3 last estimates.
33%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Aktis Oncology, Inc. Common stock earnings per share and revenue
On Aug 13, 2026, AKTS reported earnings of -0.44 USD per share (EPS) for Q2 26, missing the estimate of -0.43 USD, resulting in a -1.34% surprise. Revenue reached 3.38 million, compared to an expected 2.04 million, with a 65.88% difference. The market reacted with a +4.79% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
BioLineRX Ltd
Report Date
Aug 31, 2026 For Q2 26
Estimate
-Actual
-$0.77
Surprise
-
Galmed Pharmaceuticals Ltd.
Report Date
Sep 02, 2026 For Q2 26
Estimate
-$3.18
Actual
$2.86
Surprise
+189.87%
FAQ
What were Aktis Oncology, Inc. Common stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Aktis Oncology, Inc. Common stock reported EPS of -$0.44, missing estimates by -1.34%, and revenue of $3.38M, 65.88% above expectations.
How did the market react to Aktis Oncology, Inc. Common stock's Q2 2026 earnings?
The stock price moved up 4.79%, changed from $23.79 before the earnings release to $24.93 the day after.
When is Aktis Oncology, Inc. Common stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Aktis Oncology, Inc. Common stock's next earnings report?
Based on --
analysts, Aktis Oncology, Inc. Common stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.